PCN91 Pharmacoeconomic Analysis of mCRC Therapy With XELOX/FOLFOX4 Regimes With Bevacizumab or Cetuximab as the First Line Treatment in Russia

✍ Scribed by Tikhomirova, A.V.; Yagudina, R.I.; Kulikov, A.U.

• Book ID: 122231100
• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 72 KB
• Volume: 14
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2011.08.1192